# Yung Shin Pharmaceutical Industry Co., Ltd. – FDA Inspection, Sep 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/8f7f2129-fd49-4cea-8b37-e298723a8ffb
Source feed: FDA_Inspections

> FDA inspection 1101829 of Yung Shin Pharmaceutical Industry Co., Ltd., September 12, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101829
- Company Name: Yung Shin Pharmaceutical Industry Co., Ltd.
- Inspection Date: 2019-09-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- [FDA Inspection 1338914 - 2026-08-07](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/9a419997-58b6-4fd3-9946-e9e8e170152d)
- [FDA Inspection 1238384 - 2024-04-25](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/19516104-2382-42cb-9dc9-c0b447368ec2)
- FDA Inspection 1111111 - 2019-10-22
- [FDA Inspection 1062411 - 2018-07-27](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/30efab8d-ed52-47f1-866b-2a7f1395efa7)
- [FDA Inspection 997026 - 2016-11-24](https://www.keypedia.com/records/fda_inspections/yung-shin-pharmaceutical-industry-co-ltd/8b47e25c-5132-4471-a5b0-531b9336ea31)

## Related Officers

- [Samina S. Khan](https://www.keypedia.com/people/samina-s-khan/ca3e266c-aa69-4c28-9901-d344e0c259fd)

Company: https://www.keypedia.com/companies/yung-shin-pharmaceutical-industry-co-ltd/231493b4-19d3-4045-807b-3b0108ce15ba

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8